BASILEA PHARMACEUTICA AG

ADALUZIS

Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases;

ADALUZIS

Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases;

ADALUZIS

Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases;

ANTICIPA

Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases;The English translation of ANTICIPA in the mark is ANTICIPATE.;

BASILEA

The mark consists of the color blue appears in the wording BASILEA and in the design of the oval ring encircling the wording. The color white appears inside the ring.;Pharmaceutical preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical preparations, namely, for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anestesiology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only;The color(s) blue and white is/are claimed as a feature of the mark.;chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use;research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations;